JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB9643

Anti-PUMA antibody

4

(12 Reviews)

|

(145 Publications)

Rabbit Polyclonal PUMA antibody. Suitable for WB, ICC/IF and reacts with Human, Mouse samples. Cited in 145 publications. Immunogen corresponding to Synthetic Peptide within Human BBC3 aa 150 to C-terminus.

View Alternative Names

PUMA, BBC3, JFY-1, p53 up-regulated modulator of apoptosis

6 Images
Immunocytochemistry - Anti-PUMA antibody (AB9643)
  • ICC

Supplier Data

Immunocytochemistry - Anti-PUMA antibody (AB9643)

Immunocytochemical analysis of K562 cells labeling PUMA with ab9643 at 1 μg/mL. Cells were fixed with formaldehyde and blocked with 10% serum for 1 hour at room temperature. Antigen retrieval was by heat mediation with a citrate buffer (pH 6.0). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Immunocytochemistry/ Immunofluorescence - Anti-PUMA antibody (AB9643)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-PUMA antibody (AB9643)

Immunofluorescent analysis of 4% paraformaldehydefixed K562 cells labeling PUMA with ab9643 at 2 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red). Image showing cytosol staining on K562 cells.

Immunocytochemistry/ Immunofluorescence - Anti-PUMA antibody (AB9643)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PUMA antibody (AB9643)

ICC/IF image of ab9643 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab9643, 1μg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Western blot - Anti-PUMA antibody (AB9643)
  • WB

AbReview3861****

Western blot - Anti-PUMA antibody (AB9643)

Blocked with 5% milk for 1 hour.

Incubated with the primary antibody for 18 hours.

All lanes:

Western blot - Anti-PUMA antibody (ab9643) at 1/1000 dilution

All lanes:

HeLa whole cell lysate

Secondary

All lanes:

Alexa Fluor 680-conjugated goat anti-rabbit IgG polyclonal at 1/1 dilution

Predicted band size: 21 kDa

Observed band size: 20 kDa,26 kDa,42 kDa,50 kDa

false

Exposure time: 5s

This image is courtesy of an anonymous Abreview

Western blot - Anti-PUMA antibody (AB9643)
  • WB

Supplier Data

Western blot - Anti-PUMA antibody (AB9643)

Beta-actin (1 μg/mL) and GAPDH (0.02 μg/mL). Incubation time : 1 hour at Room Temperature in 5% NFDM/TBST.

All lanes:

Western blot - Anti-PUMA antibody (ab9643) at 2 µg/mL

Lane 1:

HEK293 cells were transfected with control siRNAs at 15 µg

Lane 2:

HEK293 cells were transfected with PUMA siRNAs at 15 µg

Secondary

All lanes:

Goat anti-rabbit IgG HRP conjugate at 1/10000 dilution

Predicted band size: 21 kDa

false

Western blot - Anti-PUMA antibody (AB9643)
  • WB

Supplier Data

Western blot - Anti-PUMA antibody (AB9643)

All lanes:

Western blot - Anti-PUMA antibody (ab9643) at 2 µg/mL

Lane 1:

K562 cell lysate at 15 µg

Lane 2:

NIH3T3 cell lysate at 15 µg

Secondary

All lanes:

Goat anti-rabbit IgG HRP conjugate at 1/10000 dilution

Predicted band size: 21 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

ICC/IF, WB

applications

Immunogen

Synthetic Peptide within Human BBC3 aa 150 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q9BXH1

Specificity

At least 2 isoforms are known to exist; this antibody will detect both isoforms.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-2 µg/mL", "WB-species-notes": "<p>Use at a concentration of 1 - 2 µg/ml. Detects a band of approximately 23 kDa. Can be blocked with PUMA peptide (180/193) (<a href='/en-us/products/unavailable/human-puma-peptide-ab9644'>ab9644</a>). A lower band at approximately 16 kDa was detected in MOLT4 and U937 cells, which may represent the PUMA-beta form.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-2 µg/mL", "WB-species-notes": "<p>Use at a concentration of 1 - 2 µg/ml. Detects a band of approximately 23 kDa. Can be blocked with PUMA peptide (180/193) (<a href='/en-us/products/unavailable/human-puma-peptide-ab9644'>ab9644</a>). A lower band at approximately 16 kDa was detected in MOLT4 and U937 cells, which may represent the PUMA-beta form.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "1 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Product details

Apoptosis is related to many diseases and development. The p53 tumor-suppressor protein induces apoptosis through transcriptional activation of several genes. A novel p53 inducible pro-apoptotic gene was identified recently and designated PUMA (for p53 upregulated modulator of apoptosis) and bbc3 (for Bcl-2 binding component 3) in human and mouse (1-3). PUMA/bbc3 is one of the pro-apoptotic Bcl-2 family members including Bax and Noxa, which are also transcriptional targets of p53. The PUMA gene encodes two BH3 domain-containing proteins termed PUMA-a and PUMA-b (1). PUMA proteins bind Bcl-2, localize to the mitochondria, and induce cytochrome c release and apoptosis in response to p53. PUMA may be a direct mediator of p53-induced apoptosis.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PUMA also known as BBC3 (Bcl-2-binding component-3) is a pro-apoptotic protein that plays important mechanical roles in promoting apoptosis. It has a mass of approximately 23 kDa. PUMA is expressed widely in various tissues including the lung liver and heart. The protein works mechanically by interacting with anti-apoptotic Bcl-2 family members releasing pro-apoptotic factors like Bax and Bak which engage mitochondria to trigger cell death.
Biological function summary

PUMA functions as a pivotal mediator of apoptosis in response to diverse stimuli such as DNA damage and oncogenic stress. As part of the Bcl-2 family PUMA does not typically form a complex with other proteins but functions directly by binding and neutralizing anti-apoptotic Bcl-2 family proteins. This action results in the release of caspase-activating factors from mitochondria essential for programmed cell death.

Pathways

Several cellular pathways incorporate PUMA to regulate apoptosis. PUMA is notably included in the p53 pathway where p53 transcriptionally activates PUMA following cellular stress or DNA damage. The presence of related proteins like Bax and Bim in the mitochondrial apoptotic pathway links these signals to the mitochondrial death machinery facilitating apoptosis.

PUMA plays significant roles in cancer and neurodegenerative conditions. PUMA overexpression induces excessive cell death relevant in the pathology of neurodegenerative diseases. In cancer PUMA's interactions with proteins like p53 highlight its involvement in tumor suppression suggesting that dysregulation of PUMA expression can contribute to tumorigenesis when anti-apoptotic signals predominate potentially leading to chemoresistance.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Essential mediator of p53/TP53-dependent and p53/TP53-independent apoptosis (PubMed : 11463391, PubMed : 23340338). Promotes partial unfolding of BCL2L1 and dissociation of BCL2L1 from p53/TP53, releasing the bound p53/TP53 to induce apoptosis (PubMed : 23340338). Regulates ER stress-induced neuronal apoptosis (By similarity).
See full target information BBC3

Publications (145)

Recent publications for all applications. Explore the full list and refine your search

Cell death discovery 11:451 PubMed41057309

2025

Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stress.

Applications

Unspecified application

Species

Unspecified reactive species

Yi-Fang Yang,Zhao-Jing He,Han-Hsi Kuo,Yu-Yu Lin,Cheorl-Ho Kim,Huei-Yu Cai,Chi-Long Chen,Michael Hsiao,Ying-Chung Chen,Peter Mu-Hsin Chang,Yu-Chan Chang

Stem cell research & therapy 16:285 PubMed40462170

2025

MiR221/222 in the conditioned medium of adipose-derived stem cells attenuates particulate matter and high-fat diet-induced cardiac apoptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Ya-Chun Chen,Chi-Ming Pu,Shu-Rung Lin,Shu-Wha Lin,I-Shing Yu,Ho-Jun Shih,Chiang-Wen Lee,Ming-Hsueh Lee,Yen-Ting Kuo,Yuh-Lien Chen

iScience 28:112380 PubMed40343270

2025

RNA splicing modulator for Huntington's disease treatment induces peripheral neuropathy.

Applications

Unspecified application

Species

Unspecified reactive species

Florian Krach,Tom Boerstler,Stephanie Neubert,Laura Krumm,Martin Regensburger,Jürgen Winkler,Beate Winner

Nucleic acids research 53: PubMed39907108

2025

Chromatin remodeler CHD4 establishes chromatin states required for ovarian reserve formation, maintenance and male germ cell survival.

Applications

Unspecified application

Species

Unspecified reactive species

Yasuhisa Munakata,Mengwen Hu,Yuka Kitamura,Raissa G Dani,Adam L Bynder,Amelia S Fritz,Richard M Schultz,Satoshi H Namekawa

BMC cancer 24:1350 PubMed39497108

2024

Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Yanhao Ji,Michael A Harris,Lucas M Newton,Tiffany J Harris,W Douglas Fairlie,Erinna F Lee,Christine J Hawkins

International journal of molecular sciences 25: PubMed39273571

2024

Protein Kinase C-Delta Mediates Cell Cycle Reentry and Apoptosis Induced by Amyloid-Beta Peptide in Post-Mitotic Cortical Neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Ming-Hsuan Wu,A-Ching Chao,Yi-Heng Hsieh,You Lien,Yi-Chun Lin,Ding-I Yang

Autophagy 21:374-393 PubMed39245438

2024

and -enriched adsc-exosomes mitigate PM exposure-exacerbated cardiac ischemia-reperfusion injury through the modulation of the BNIP3-MAP1LC3B-BBC3/PUMA pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Tzu-Lin Lee,Wen-Chi Shen,Ya-Chun Chen,Tsai-Chun Lai,Shu-Rung Lin,Shu-Wha Lin,I-Shing Yu,Yen-Hsiu Yeh,Tsai-Kun Li,I-Ta Lee,Chiang-Wen Lee,Yuh-Lien Chen

Cancer letters 598:217126 PubMed39053726

2024

An MDM2 degrader shows potent cytotoxicity to MDM2-overexpressing acute lymphoblastic leukemia cells with minimal toxicity to normal cells/tissues.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Liu,Lubing Gu,Anna Mui,Zhongzhi Wu,Najah Albadari,Wei Li,Muxiang Zhou

Genes & diseases 11:100977 PubMed38292193

2024

Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma.

Applications

Unspecified application

Species

Unspecified reactive species

Zongze He,Bo Peng,Qi Wang,Jie Tian,Ping Liu,Jie Feng,Yiwei Liao,Longyi Chen,Ping Jia,Jian Tang

Cellular & molecular biology letters 28:104 PubMed38093179

2023

Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Ming Lei,Hui Lin,Deyao Shi,Pan Hong,Hui Song,Bomansaan Herman,Zhiwei Liao,Cao Yang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com